Deals
Bayer Faces In-Depth EU Review of $66 Billion Monsanto Deal
- EU sets Jan. 8 deadline for last in trio of mega-mergers
- EU flags concerns over higher prices and reduced innovation
This article is for subscribers only.
Bayer AG faces months of haggling with European Union antitrust regulators who opened an in-depth probe into its $66 billion combination with Monsanto Co. amid concerns the takeover may reduce competition for pesticides, seeds and plant traits.
The European Commission flagged worries that the deal to create the world’s largest pesticides and seeds company risked raising prices for farmers, lowering quality and reducing choice and innovation. It set a Jan. 8 deadline for its merger investigation.